Firsocostat is an acetyl-CoA carboxylase inhibitor that functions in the liver.

Its original designation was GS-0976.

[1] It was discovered by Nimbus Therapeutics.

[2] The drug is under development by Gilead as a treatment for non-alcoholic fatty liver disease.

[3]